| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Anticoagulant treatment for venous thromboembolism: A pooled analysis and additional results of the XALIA and XALIA‐LEA noninterventional studies
|
Haas, Sylvia
|
|
|
5 |
3 |
p. 426-438
|
article
|
| 2 |
Anticoagulated patients exhibit intact endogenous thrombin potential using ST Genesia unlike the Calibrated Automated Thrombogram
|
Helin, Tuukka A.
|
|
|
5 |
3 |
p. 439-446
|
article
|
| 3 |
Apixaban in low‐weight patients with cancer‐associated thrombosis: A cross sectional study of drug levels
|
Bravo Villa, Verónica
|
|
|
5 |
3 |
p. 421-425
|
article
|
| 4 |
Erratum
|
|
|
|
5 |
3 |
p. 456
|
article
|
| 5 |
Exploring the utility of a novel point‐of‐care whole blood thrombin generation assay following trauma: A pilot study
|
Ferrara, Michael J.
|
|
|
5 |
3 |
p. 395-402
|
article
|
| 6 |
Fluorescence artifact correction in the thrombin generation assay: Necessity for correction algorithms in procoagulant samples
|
Chang, William C.
|
|
|
5 |
3 |
p. 447-455
|
article
|
| 7 |
Innovation via social media – The importance of Twitter to science
|
Cormier, Matthew
|
|
|
5 |
3 |
p. 373-375
|
article
|
| 8 |
Issue Information
|
|
|
|
5 |
3 |
p. i, 369-372
|
article
|
| 9 |
Patient selection for hemophilia gene therapy: Real‐life data from a single center
|
Krumb, Evelien
|
|
|
5 |
3 |
p. 390-394
|
article
|
| 10 |
Platelet Src family kinases: A tale of reversible phosphorylation
|
Senis, Yotis A.
|
|
|
5 |
3 |
p. 376-389
|
article
|
| 11 |
Risk of thrombotic complications in influenza versus COVID‐19 hospitalized patients
|
Stals, Milou A.M.
|
|
|
5 |
3 |
p. 412-420
|
article
|
| 12 |
Updating the Canadian Hemophilia Outcomes–Kids’ Life Assessment Tool (CHO‐KLAT) in the era of extended half‐life clotting factor concentrates
|
Price, Victoria E.
|
|
|
5 |
3 |
p. 403-411
|
article
|
Journal description